Clinical Challenges: Tx Choices in Newly Diagnosed Multiple Myeloma

Clinicians should focus on picking regimens with established safety and efficacy record

Related Keywords

Delaware ,United States ,University Of Pennsylvania ,Pennsylvania ,Philadelphia ,American ,Leah Lawrence ,Pconsider Comorbidities ,Alfredl Garfall ,American Society Of Hematology ,International Myeloma Working Group ,Hospital Of The University Pennsylvania ,Myeloma ,Multiple Myeloma ,Lenalidomide ,Peripheral Neuropathy ,Bortezomib ,